188 related articles for article (PubMed ID: 8625970)
21. Preservation of the specificity of superantigen to T cell receptor V beta elements in the absence of MHC class II molecules.
Kotb M; Watanabe-Ohnishi R; Aelion J; Tanaka T; Geller AM; Ohnishi H
Cell Immunol; 1993 Dec; 152(2):348-57. PubMed ID: 8258143
[TBL] [Abstract][Full Text] [Related]
22. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
[TBL] [Abstract][Full Text] [Related]
23. Implantation of IL-2-containing osmotic pump prolongs the survival of superantigen-reactive T cells expanded in mice injected with bacterial superantigen.
Kuroda K; Yagi J; Imanishi K; Yan XJ; Li XY; Fujimaki W; Kato H; Miyoshi-Akiyama T; Kumazawa Y; Abe H; Uchiyama T
J Immunol; 1996 Aug; 157(4):1422-31. PubMed ID: 8759722
[TBL] [Abstract][Full Text] [Related]
24. A role for antigen-presenting cells and bacterial superantigens in reversal of human T lymphocyte anergy.
Burns J; Littlefield K
Eur J Immunol; 1993 Dec; 23(12):3300-5. PubMed ID: 7504993
[TBL] [Abstract][Full Text] [Related]
25. Dissociation of antigen-presenting capacity of astrocytes for peptide-antigens versus superantigens.
Rott O; Tontsch U; Fleischer B
J Immunol; 1993 Jan; 150(1):87-95. PubMed ID: 7678036
[TBL] [Abstract][Full Text] [Related]
26. In vitro T cell responses to a candidate Epstein-Barr virus vaccine: human CD4+ T cell clones specific for the major envelope glycoprotein gp340.
Ulaeto D; Wallace L; Morgan A; Morein B; Rickinson AB
Eur J Immunol; 1988 Nov; 18(11):1689-97. PubMed ID: 2904885
[TBL] [Abstract][Full Text] [Related]
27. A kinetic comparative study on lymphocyte responses to superantigen and phytohemagglutinin: reciprocal presentation of superantigen on the surface of activated lymphocytes.
Ijichi S; Yamano Y; Osame M; Hall WW
Cell Immunol; 1996 Nov; 173(2):312-6. PubMed ID: 8912892
[TBL] [Abstract][Full Text] [Related]
28. Human thymic epithelial cells present superantigens to T-cell lines and thymocytes.
Jłrgensen A; Nielsen M; Svejgaard A; Ledbetter JA; Odum N; Röpke C
Exp Clin Immunogenet; 1996; 13(3-4):192-203. PubMed ID: 9165273
[TBL] [Abstract][Full Text] [Related]
29. Accessory cell function of keratinocytes for superantigens. Dependence on lymphocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction.
Nickoloff BJ; Mitra RS; Green J; Zheng XG; Shimizu Y; Thompson C; Turka LA
J Immunol; 1993 Mar; 150(6):2148-59. PubMed ID: 8450207
[TBL] [Abstract][Full Text] [Related]
30. Failure of correlation between B7 expression and activation of interleukin-2-secreting T cells.
Lombardi G; Sidhu S; Dodi T; Batchelor R; Lechler R
Eur J Immunol; 1994 Mar; 24(3):523-30. PubMed ID: 7510233
[TBL] [Abstract][Full Text] [Related]
31. [Requirement of class II and membrane proximal region of mouse mammary tumor virus superantigen (Mtv SAG) in Mtv7 SAG presentation].
Okamoto M; Kimura S; Katagiri M
Hokkaido Igaku Zasshi; 1998 May; 73(3):205-14. PubMed ID: 9719947
[TBL] [Abstract][Full Text] [Related]
32. Macrophages are dispensable for superantigen-mediated stimulation and anergy induction of peripheral T cells in vivo.
Koesling M; Rott O; Fleischer B
Cell Immunol; 1994 Aug; 157(1):29-37. PubMed ID: 8039249
[TBL] [Abstract][Full Text] [Related]
33. Alloantigen presentation by B cells: analysis of the requirement for B-cell activation.
Wilson JL; Cunningham AC; Kirby JA
Immunology; 1995 Nov; 86(3):325-30. PubMed ID: 8550066
[TBL] [Abstract][Full Text] [Related]
34. Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes.
Frandji P; Tkaczyk C; Oskeritzian C; David B; Desaymard C; Mécheri S
Eur J Immunol; 1996 Oct; 26(10):2517-28. PubMed ID: 8898968
[TBL] [Abstract][Full Text] [Related]
35. Superantigen reactivity of gamma delta T cell clones isolated from patients with multiple sclerosis and controls.
Stinissen P; Vandevyver C; Raus J; Zhang J
Cell Immunol; 1995 Dec; 166(2):227-35. PubMed ID: 7497524
[TBL] [Abstract][Full Text] [Related]
36. Superantigen and HLA-DR ligation induce phospholipase-C gamma 1 activation in class II+ T cells.
Kanner SB; Odum N; Grosmaire L; Masewicz S; Svejgaard A; Ledbetter JA
J Immunol; 1992 Dec; 149(11):3482-8. PubMed ID: 1385526
[TBL] [Abstract][Full Text] [Related]
37. Schwann cells co-cultured with stimulated T cells and antigen express major histocompatibility complex (MHC) class II determinants without interferon-gamma pretreatment: synergistic effects of interferon-gamma and tumor necrosis factor on MHC class II induction.
Kingston AE; Bergsteinsdottir K; Jessen KR; Van der Meide PH; Colston MJ; Mirsky R
Eur J Immunol; 1989 Jan; 19(1):177-83. PubMed ID: 2493382
[TBL] [Abstract][Full Text] [Related]
38. Partial activation of human T cells by peptide analogs on live APC: induction of clonal anergy associated with protein tyrosine dephosphorylation.
Matsushita S; Nishimura Y
Hum Immunol; 1997 Mar; 53(1):73-80. PubMed ID: 9127150
[TBL] [Abstract][Full Text] [Related]
39. Control of the rat T cell response to retroviral and bacterial superantigens by class II MHC products and Tcrb-V8.2 alleles.
Herrmann T; Hochgrebe T; Torres-Nagel NE; Huber BT; Hünig T
J Immunol; 1994 May; 152(9):4300-9. PubMed ID: 8157953
[TBL] [Abstract][Full Text] [Related]
40. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
Yamamoto M; Yano A
J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]